Granules India Limited (GRANULES.NS)
INR 464.4
(2.9%)
INR 464.4
(2.9%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 6.52 Billion INR | -17.06% |
| 2022 | 7.82 Billion INR | 36.1% |
| 2021 | 5.74 Billion INR | -21.02% |
| 2020 | 7.27 Billion INR | 51.16% |
| 2019 | 4.81 Billion INR | 72.52% |
| 2018 | 2.78 Billion INR | 37.24% |
| 2017 | 2.03 Billion INR | -14.45% |
| 2016 | 2.37 Billion INR | 9.04% |
| 2015 | 2.17 Billion INR | 37.19% |
| 2014 | 1.58 Billion INR | 20.92% |
| 2013 | 1.31 Billion INR | 109.13% |
| 2012 | 628.14 Million INR | 6.35% |
| 2011 | 590.66 Million INR | 52.44% |
| 2010 | 387.46 Million INR | -11.81% |
| 2009 | 439.34 Million INR | 0.0% |
| 2008 | - INR | -100.0% |
| 2007 | 256.31 Million INR | 10.83% |
| 2006 | 231.25 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 2.06 Billion INR | 1.91% |
| 2023 Q2 | 1.61 Billion INR | 84.22% |
| 2023 FY | 6.48 Billion INR | -17.06% |
| 2023 Q1 | 879.3 Million INR | -51.9% |
| 2023 Q4 | 2.02 Billion INR | 1.9% |
| 2023 Q3 | 1.98 Billion INR | 22.69% |
| 2022 Q2 | 2.03 Billion INR | 17.84% |
| 2022 FY | 7.82 Billion INR | 36.1% |
| 2022 Q4 | 1.82 Billion INR | -0.59% |
| 2022 Q3 | 1.83 Billion INR | -9.7% |
| 2022 Q1 | 1.72 Billion INR | 19.09% |
| 2021 Q1 | 1.62 Billion INR | -4.29% |
| 2021 FY | 5.74 Billion INR | -21.02% |
| 2021 Q3 | 1.39 Billion INR | 25.18% |
| 2021 Q2 | 1.11 Billion INR | -31.29% |
| 2021 Q4 | 1.45 Billion INR | 4.11% |
| 2020 Q2 | 2.2 Billion INR | 47.38% |
| 2020 Q1 | 1.49 Billion INR | 53.76% |
| 2020 Q4 | 1.69 Billion INR | -3.09% |
| 2020 Q3 | 1.74 Billion INR | -20.71% |
| 2020 FY | 7.27 Billion INR | 51.16% |
| 2019 Q1 | 899.5 Million INR | 27.37% |
| 2019 FY | 4.81 Billion INR | 72.52% |
| 2019 Q2 | 1.13 Billion INR | 25.94% |
| 2019 Q3 | 1.24 Billion INR | 9.6% |
| 2019 Q4 | 972.38 Million INR | -21.68% |
| 2018 Q3 | 862.93 Million INR | 16.61% |
| 2018 Q2 | 740.02 Million INR | 53.95% |
| 2018 FY | 2.78 Billion INR | 37.24% |
| 2018 Q1 | 480.7 Million INR | 106.98% |
| 2018 Q4 | 706.22 Million INR | -18.16% |
| 2017 Q4 | 232.24 Million INR | -58.0% |
| 2017 Q3 | 552.94 Million INR | -15.13% |
| 2017 Q2 | 651.49 Million INR | 9.78% |
| 2017 FY | 2.03 Billion INR | -14.45% |
| 2017 Q1 | 593.44 Million INR | -0.02% |
| 2016 FY | 2.37 Billion INR | 9.04% |
| 2016 Q2 | 596.17 Million INR | 8.02% |
| 2016 Q4 | 593.57 Million INR | 3.42% |
| 2016 Q1 | 551.92 Million INR | -13.15% |
| 2016 Q3 | 573.96 Million INR | -3.73% |
| 2015 Q4 | 635.5 Million INR | 18.56% |
| 2015 FY | 2.17 Billion INR | 37.19% |
| 2015 Q3 | 536.02 Million INR | -2.35% |
| 2015 Q2 | 548.92 Million INR | 11.5% |
| 2015 Q1 | 492.29 Million INR | 37.71% |
| 2014 Q1 | 415.53 Million INR | 4.99% |
| 2014 Q2 | 398.14 Million INR | -4.18% |
| 2014 Q3 | 417.33 Million INR | 4.82% |
| 2014 Q4 | 357.48 Million INR | -14.34% |
| 2014 FY | 1.58 Billion INR | 20.92% |
| 2013 Q2 | 277.66 Million INR | 15.22% |
| 2013 Q1 | 240.99 Million INR | 13.71% |
| 2013 FY | 1.31 Billion INR | 109.13% |
| 2013 Q4 | 395.8 Million INR | 3.8% |
| 2013 Q3 | 381.3 Million INR | 37.32% |
| 2012 Q3 | 133.84 Million INR | -14.04% |
| 2012 Q4 | 211.94 Million INR | 58.35% |
| 2012 Q1 | 127.06 Million INR | 0.0% |
| 2012 FY | 628.14 Million INR | 6.35% |
| 2012 Q2 | 155.71 Million INR | 22.54% |
| 2011 FY | 590.66 Million INR | 52.44% |
| 2010 FY | 387.46 Million INR | -11.81% |
| 2009 FY | 439.34 Million INR | 0.0% |
| 2008 FY | - INR | -100.0% |
| 2007 FY | 256.31 Million INR | 10.83% |
| 2006 FY | 231.25 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Hester Biosciences Limited | 364.77 Million INR | -1689.692% |
| RPG Life Sciences Limited | 2.29 Billion INR | -184.791% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -41.683% |
| Ipca Laboratories Limited | 29.59 Billion INR | 77.942% |
| Aarti Drugs Limited | 7.14 Billion INR | 8.679% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -108.696% |
| Albert David Limited | 1.33 Billion INR | -389.207% |
| Alembic Limited | 767.77 Million INR | -750.288% |
| Alkem Laboratories Limited | 19.46 Billion INR | 66.456% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -13.375% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -2646.879% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -31504.667% |
| Brooks Laboratories Limited | -72.25 Million INR | 9135.404% |
| Eris Lifesciences Limited | 5.18 Billion INR | -25.986% |
| FDC Limited | 3.03 Billion INR | -115.189% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 27.296% |
| Gufic Biosciences Limited | 2.89 Billion INR | -125.594% |
| Hikal Limited | 1.49 Billion INR | -336.907% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -224.945% |
| Ind-Swift Limited | 1.22 Billion INR | -432.5% |
| Innova Captab Limited | 2.53 Billion INR | -157.687% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | -32.092% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -2950.019% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -25.81% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -3037.832% |
| Laurus Labs Limited | 3.94 Billion INR | -65.331% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -242.452% |
| Lupin Limited | 27.75 Billion INR | 76.482% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -23675.439% |
| Medico Remedies Limited | 277.11 Million INR | -2255.769% |
| Morepen Laboratories Limited | 4.17 Billion INR | -56.409% |
| Nectar Lifesciences Limited | 3.89 Billion INR | -67.796% |
| Orchid Pharma Limited | 2.36 Billion INR | -176.495% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -134.324% |
| Sigachi Industries Limited | 1.47 Billion INR | -342.925% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 269.438% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 93.741% |
| Themis Medicare Limited | 1.3 Billion INR | -400.977% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Vaishali Pharma Limited | 6.29 Million INR | -103621.957% |
| Venus Remedies Limited | 534.65 Million INR | -1121.032% |
| Wanbury Limited | 1.7 Billion INR | -282.394% |
| Windlas Biotech Limited | 1.29 Billion INR | -402.603% |
| ZIM Laboratories Limited | 1.09 Billion INR | -494.498% |
| Sakar Healthcare Limited | 495.5 Million INR | -1217.494% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 93.753% |
| Divi's Laboratories Limited | 18.31 Billion INR | 64.346% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | -45.919% |
| Mankind Pharma Limited | 40.86 Billion INR | 84.026% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Neuland Laboratories Limited | 5.31 Billion INR | -22.756% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 13.437% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | -0.398% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 85.618% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -951.204% |
| Wockhardt Limited | 140 Million INR | -4563.043% |
| Bal Pharma Limited | 214.56 Million INR | -2942.499% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 90.361% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -430.321% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -1083.537% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | 9.647% |
| Shilpa Medicare Limited | 3.76 Billion INR | -73.551% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 19.67 Billion INR | 66.823% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -230513.256% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -2519.151% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 74.232% |
| NATCO Pharma Limited | 25.96 Billion INR | 74.855% |
| Suven Life Sciences Limited | -1.22 Billion INR | 632.562% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | -24.923% |
| Indoco Remedies Limited | 1.52 Billion INR | -328.251% |
| Alpa Laboratories Limited | 61.51 Million INR | -10512.469% |
| Lasa Supergenerics Limited | -458 Million INR | 1525.369% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 258.644% |